Skip to content

Acupuncture combined with Tamsulosin hydrochloride sustained-release capsule in the treatment of Chronic prostatitis/Chronic pelvic pain syndrome: A study protocol for a randomized controlled trial

Acupuncture combined with Tamsulosin hydrochloride sustained-release capsule in the treatment of Chronic prostatitis/Chronic pelvic pain syndrome: A study protocol for a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021132
Enrollment
Unknown
Registered
2019-01-29
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic prostatitis/Chronic pelvic pain syndrome

Interventions

Group 2:Tamsulosin hydrochloride sustained-release capsule
Group 1:Acupuncture combined with tamsulosin hydrochloride sustained-release capsule

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Male patients diagnosed with Chronic prostatitis/Chronic pelvic pain syndrome will be included (refer to the National Institutes of Health diagnostic criteria for the diagnosis and treatment of Chronic prostatitis/Chronic pelvic pain syndrome); 2. Patient aged 20 to 50 years old; 3. Voluntary Participants in the study; 4. Patients informed consent.

Exclusion criteria

Exclusion criteria: 1. does not meet the diagnostic criteria; 2. pelvic surgery history or within 6 months; 3 complicated by genitourinary dysplasia or infection; 3. prostate tuberculosis, benign prostatic hyperplasia and prostate cancer, acute urethral syndrome; 4. with serious Physical illness, systemic failure, and allergy to tamsulosin; 5. patients taking other drugs for prostate disease 2 weeks before treatment; 6. those who refused to participate in the study and did not sign informed consent. For the above 7 exclusion criteria, as long as one of the criteria is met, the exclusion criteria are met and need to be excluded.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health's Symptom Score Index score;

Secondary

MeasureTime frame
Prostate texture score;

Countries

China

Contacts

Public ContactJi-sheng Wang

Department of Andrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing China

houdejishegn@sina.com+86 13720022330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026